SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision — making for Emerging Therapeutics

For best results when printing this announcement, please click on link below: SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emerging Therapeutics SCIEX ( ), a Danaher company and leader in life science analytical technologies, today announced new capillary electrophoresis (CE) capabilities for the BioPhase 8800 system that help laboratories accelerate development timelines, strengthen compliance, and integrate more seamlessly into automated workflows. Combining enhanced software, automation connectivity, and expanded analytical support for emerging oligonucleotide-based therapeutics, the updates.